Search

everythinglearnresearchcommunity

for

Search:↓

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Understanding gene expression in hair follicles can reveal insights into hair growth and disorders.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Different types of fibroblasts play various roles in diseases and healing, and more research on them could improve treatments.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Epithelial-mesenchymal interactions control hair growth cycles through specific molecular signals.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Jumonji genes are important for development and their mutations can cause abnormalities, especially in the heart and brain.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hair loss needs more research for better treatments.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Stem cells in the hair follicle are regulated by their surrounding environment, which is important for hair growth.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

The document concludes that understanding the sebaceous gland's development and function is key to addressing related skin diseases and aging effects.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Future acne treatments should aggressively target inflammation to prevent scarring.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.